Structure-Aided Computational Design of Triazole-Based Targeted Covalent Inhibitors of Cruzipain.

Juan Pablo Cerutti1,2, Lucas Abreu Diniz3, Viviane Corrêa Santos3

  • 1Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA-CONICET), Facultad de Ciencias Químicas, Universidad Nacional de Córdoba (FCQ-UNC), Haya de la Torre y Medina Allende, Córdoba 5000, Argentina.

PubMed
Summary

Researchers developed novel triazole compounds targeting cruzipain (CZP), a key enzyme in Chagas disease. One compound, Ald-6, shows potent anti-parasitic activity and low toxicity, making it a promising candidate for further drug development.